Astera Labs (NASDAQ:ALAB) Shares Up 11.3% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB) shares rose 11.3% during mid-day trading on Thursday . The company traded as high as $421.20 and last traded at $417.07. Approximately 22,491,790 shares traded hands during mid-day trading, an increase of 297% from the average daily volume of 5,663,318 shares. The stock had previously closed at $374.68.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Barclays boosted their target price on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Loop Capital assumed coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target for the company. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Needham & Company LLC boosted their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Finally, Citigroup cut shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus price target of $233.75.

Astera Labs Stock Performance

The company has a market cap of $71.49 billion, a P/E ratio of 281.80, a PEG ratio of 5.52 and a beta of 3.95. The stock’s 50 day moving average is $264.43 and its 200-day moving average is $187.34.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s revenue was up 93.5% compared to the same quarter last year. During the same period last year, the business earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Activity

In related news, CEO Jitendra Mohan sold 28,737 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the completion of the sale, the chief executive officer owned 3,789,232 shares of the company’s stock, valued at $945,868,091.84. This trade represents a 0.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 2,161,256 shares of company stock valued at $459,844,296. Company insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Empowered Funds LLC increased its holdings in Astera Labs by 5.1% in the 1st quarter. Empowered Funds LLC now owns 9,606 shares of the company’s stock worth $1,053,000 after buying an additional 462 shares in the last quarter. Carmignac Gestion bought a new stake in shares of Astera Labs in the first quarter worth approximately $6,576,000. Shariaportfolio Inc. purchased a new position in shares of Astera Labs during the first quarter valued at approximately $5,304,000. Glenmede Trust Co. NA raised its holdings in shares of Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares during the last quarter. Finally, Verus Capital Partners LLC lifted its position in Astera Labs by 16.4% during the first quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock valued at $422,000 after purchasing an additional 541 shares during the period. 60.47% of the stock is owned by institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.